| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 128 | 2025 | 3733 | 21.180 |
Why?
|
| Rheumatic Diseases | 47 | 2025 | 622 | 9.390 |
Why?
|
| Lung Diseases, Interstitial | 32 | 2024 | 939 | 8.930 |
Why?
|
| Antirheumatic Agents | 44 | 2025 | 1365 | 8.250 |
Why?
|
| Rheumatology | 23 | 2024 | 602 | 4.330 |
Why?
|
| Autoimmune Diseases | 17 | 2025 | 2226 | 2.620 |
Why?
|
| Smoking | 25 | 2024 | 9081 | 2.520 |
Why?
|
| Methotrexate | 15 | 2025 | 1722 | 2.210 |
Why?
|
| Bronchiectasis | 3 | 2024 | 141 | 2.180 |
Why?
|
| Lupus Erythematosus, Systemic | 22 | 2024 | 2159 | 1.750 |
Why?
|
| Hydroxychloroquine | 11 | 2021 | 431 | 1.740 |
Why?
|
| Rheumatoid Factor | 8 | 2023 | 183 | 1.730 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 9 | 2024 | 3247 | 1.700 |
Why?
|
| Arthritis, Psoriatic | 5 | 2023 | 216 | 1.510 |
Why?
|
| Risk Factors | 82 | 2025 | 74840 | 1.340 |
Why?
|
| Nurses | 17 | 2024 | 2505 | 1.290 |
Why?
|
| Biological Products | 8 | 2024 | 942 | 1.200 |
Why?
|
| Autoantibodies | 14 | 2024 | 2113 | 1.130 |
Why?
|
| Women's Health | 4 | 2021 | 2084 | 1.110 |
Why?
|
| Sarcoidosis | 3 | 2019 | 532 | 1.110 |
Why?
|
| Humans | 243 | 2025 | 765968 | 1.110 |
Why?
|
| Health Behavior | 5 | 2022 | 2650 | 1.090 |
Why?
|
| Middle Aged | 120 | 2025 | 223009 | 1.050 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2021 | 827 | 1.050 |
Why?
|
| Asthma | 8 | 2023 | 6270 | 1.040 |
Why?
|
| Autoimmunity | 4 | 2024 | 1354 | 1.030 |
Why?
|
| Arthritis | 3 | 2024 | 677 | 0.980 |
Why?
|
| Risk Reduction Behavior | 4 | 2021 | 1123 | 0.970 |
Why?
|
| Air Pollution | 3 | 2024 | 2380 | 0.920 |
Why?
|
| Lung Transplantation | 2 | 2024 | 1311 | 0.920 |
Why?
|
| Incidence | 33 | 2024 | 21480 | 0.920 |
Why?
|
| Female | 140 | 2025 | 396112 | 0.920 |
Why?
|
| Sinusitis | 3 | 2024 | 995 | 0.910 |
Why?
|
| Glucocorticoids | 12 | 2024 | 2132 | 0.900 |
Why?
|
| Disease Progression | 13 | 2024 | 13632 | 0.890 |
Why?
|
| Case-Control Studies | 27 | 2024 | 22223 | 0.880 |
Why?
|
| Spirometry | 2 | 2024 | 929 | 0.870 |
Why?
|
| Prospective Studies | 47 | 2025 | 54802 | 0.840 |
Why?
|
| Bone Diseases | 2 | 2019 | 411 | 0.840 |
Why?
|
| Gout | 4 | 2022 | 620 | 0.780 |
Why?
|
| Adult | 90 | 2025 | 223044 | 0.770 |
Why?
|
| Male | 99 | 2025 | 363698 | 0.740 |
Why?
|
| Antigens, Viral | 1 | 2024 | 995 | 0.690 |
Why?
|
| Patient Education as Topic | 4 | 2019 | 2334 | 0.680 |
Why?
|
| Smoking Cessation | 4 | 2019 | 2084 | 0.660 |
Why?
|
| Psoriasis | 3 | 2023 | 919 | 0.660 |
Why?
|
| Risk Assessment | 25 | 2025 | 24282 | 0.660 |
Why?
|
| Air Pollutants | 3 | 2024 | 2923 | 0.650 |
Why?
|
| Aged | 60 | 2025 | 171117 | 0.640 |
Why?
|
| Antimalarials | 3 | 2020 | 913 | 0.640 |
Why?
|
| Pulmonary Emphysema | 1 | 2024 | 683 | 0.630 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2019 | 45 | 0.630 |
Why?
|
| Early Diagnosis | 1 | 2024 | 1187 | 0.620 |
Why?
|
| Mucin-5B | 4 | 2023 | 148 | 0.610 |
Why?
|
| Climate Change | 1 | 2024 | 509 | 0.580 |
Why?
|
| Life Style | 6 | 2022 | 3926 | 0.560 |
Why?
|
| Gastrointestinal Agents | 1 | 2021 | 510 | 0.540 |
Why?
|
| Environmental Exposure | 5 | 2024 | 4544 | 0.540 |
Why?
|
| Pneumonia | 2 | 2020 | 2157 | 0.540 |
Why?
|
| Antiviral Agents | 4 | 2024 | 3050 | 0.530 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2018 | 187 | 0.530 |
Why?
|
| Public Opinion | 1 | 2020 | 482 | 0.530 |
Why?
|
| Peptides, Cyclic | 4 | 2022 | 390 | 0.530 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 438 | 0.530 |
Why?
|
| Coronavirus Infections | 8 | 2021 | 3100 | 0.520 |
Why?
|
| Sulfasalazine | 1 | 2016 | 85 | 0.520 |
Why?
|
| Lung | 11 | 2024 | 10033 | 0.500 |
Why?
|
| Immunosuppressive Agents | 4 | 2022 | 4209 | 0.500 |
Why?
|
| Drug Monitoring | 1 | 2021 | 962 | 0.500 |
Why?
|
| Seafood | 1 | 2019 | 395 | 0.500 |
Why?
|
| Diet | 7 | 2024 | 8086 | 0.490 |
Why?
|
| Fusarium | 1 | 2015 | 50 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 4058 | 0.490 |
Why?
|
| Sex Factors | 9 | 2025 | 10603 | 0.490 |
Why?
|
| Gastritis | 1 | 2017 | 200 | 0.490 |
Why?
|
| Bariatric Surgery | 3 | 2020 | 997 | 0.480 |
Why?
|
| Health Education | 2 | 2018 | 1060 | 0.480 |
Why?
|
| Granuloma | 1 | 2017 | 327 | 0.480 |
Why?
|
| Pneumonia, Viral | 7 | 2020 | 3223 | 0.460 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 358 | 0.460 |
Why?
|
| Registries | 11 | 2023 | 8297 | 0.460 |
Why?
|
| Family | 2 | 2016 | 3209 | 0.460 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1792 | 0.420 |
Why?
|
| Vital Capacity | 3 | 2024 | 995 | 0.410 |
Why?
|
| Antibodies, Antinuclear | 5 | 2024 | 340 | 0.410 |
Why?
|
| United States | 33 | 2025 | 72903 | 0.390 |
Why?
|
| Time Factors | 18 | 2024 | 40065 | 0.390 |
Why?
|
| Vaccination | 12 | 2024 | 3426 | 0.390 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 15652 | 0.380 |
Why?
|
| Arthritis, Infectious | 1 | 2015 | 345 | 0.380 |
Why?
|
| Proportional Hazards Models | 13 | 2021 | 12509 | 0.380 |
Why?
|
| Myositis | 3 | 2024 | 270 | 0.380 |
Why?
|
| Retrospective Studies | 19 | 2025 | 81514 | 0.370 |
Why?
|
| Cohort Studies | 23 | 2025 | 41649 | 0.370 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1462 | 0.360 |
Why?
|
| Respiratory Function Tests | 5 | 2024 | 1693 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2024 | 18071 | 0.340 |
Why?
|
| Severity of Illness Index | 7 | 2022 | 15880 | 0.330 |
Why?
|
| Logistic Models | 9 | 2022 | 13266 | 0.320 |
Why?
|
| Exercise | 4 | 2022 | 5937 | 0.320 |
Why?
|
| Lung Diseases | 1 | 2019 | 1940 | 0.320 |
Why?
|
| Connective Tissue Diseases | 3 | 2024 | 284 | 0.320 |
Why?
|
| Obesity | 6 | 2020 | 13076 | 0.310 |
Why?
|
| Environment | 1 | 2014 | 1114 | 0.300 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 1396 | 0.300 |
Why?
|
| Physicians | 2 | 2023 | 4588 | 0.290 |
Why?
|
| Serologic Tests | 2 | 2021 | 382 | 0.290 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2019 | 64 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 2 | 2024 | 9249 | 0.290 |
Why?
|
| Prednisone | 5 | 2023 | 1565 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2310 | 0.280 |
Why?
|
| Body Weight | 1 | 2017 | 4622 | 0.270 |
Why?
|
| Musculoskeletal Diseases | 2 | 2023 | 598 | 0.270 |
Why?
|
| Neoplasms | 5 | 2024 | 22340 | 0.270 |
Why?
|
| Body Mass Index | 9 | 2021 | 13039 | 0.260 |
Why?
|
| Immunologic Factors | 3 | 2024 | 1587 | 0.260 |
Why?
|
| Prevalence | 6 | 2023 | 15842 | 0.260 |
Why?
|
| Inflammation | 6 | 2024 | 10850 | 0.250 |
Why?
|
| Immunophenotyping | 3 | 2025 | 1866 | 0.250 |
Why?
|
| Pandemics | 10 | 2023 | 8703 | 0.250 |
Why?
|
| Hospitalization | 9 | 2025 | 10808 | 0.250 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13451 | 0.240 |
Why?
|
| Risk | 4 | 2021 | 9591 | 0.230 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12437 | 0.230 |
Why?
|
| Scleroderma, Systemic | 3 | 2024 | 346 | 0.230 |
Why?
|
| Research Design | 4 | 2022 | 6209 | 0.230 |
Why?
|
| Remission Induction | 3 | 2021 | 2411 | 0.220 |
Why?
|
| Bone and Bones | 1 | 2014 | 2554 | 0.220 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 3211 | 0.210 |
Why?
|
| Age Factors | 7 | 2020 | 18380 | 0.210 |
Why?
|
| I-kappa B Kinase | 1 | 2024 | 248 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 1857 | 0.210 |
Why?
|
| Adenosine Monophosphate | 1 | 2024 | 231 | 0.210 |
Why?
|
| Ikaros Transcription Factor | 1 | 2024 | 230 | 0.210 |
Why?
|
| Odds Ratio | 6 | 2022 | 9649 | 0.200 |
Why?
|
| Folic Acid | 2 | 2021 | 1338 | 0.200 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2024 | 156 | 0.200 |
Why?
|
| Influenza, Human | 1 | 2013 | 1539 | 0.200 |
Why?
|
| Forced Expiratory Volume | 2 | 2024 | 1828 | 0.200 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2023 | 125 | 0.190 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2023 | 226 | 0.190 |
Why?
|
| Alanine | 1 | 2024 | 612 | 0.190 |
Why?
|
| Oral Health | 2 | 2019 | 493 | 0.190 |
Why?
|
| Comorbidity | 8 | 2024 | 10563 | 0.180 |
Why?
|
| Depression | 1 | 2021 | 8237 | 0.180 |
Why?
|
| Lymphoma, T-Cell | 1 | 2023 | 309 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2022 | 5786 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2268 | 0.180 |
Why?
|
| Myasthenia Gravis | 1 | 2023 | 214 | 0.180 |
Why?
|
| Interleukin-12 | 1 | 2023 | 579 | 0.170 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 4040 | 0.170 |
Why?
|
| Emphysema | 1 | 2022 | 234 | 0.170 |
Why?
|
| Treatment Outcome | 9 | 2023 | 65188 | 0.170 |
Why?
|
| Thorax | 1 | 2022 | 554 | 0.160 |
Why?
|
| Premature Birth | 2 | 2023 | 1829 | 0.160 |
Why?
|
| Drug Resistance, Viral | 1 | 2024 | 866 | 0.160 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 621 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 605 | 0.160 |
Why?
|
| Postmenopause | 2 | 2018 | 2515 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2022 | 552 | 0.160 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2020 | 166 | 0.160 |
Why?
|
| Health Surveys | 3 | 2019 | 4056 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2024 | 16047 | 0.150 |
Why?
|
| Single-Cell Analysis | 3 | 2025 | 2535 | 0.150 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 4270 | 0.150 |
Why?
|
| Nutritive Value | 1 | 2021 | 351 | 0.150 |
Why?
|
| Immunocompromised Host | 2 | 2020 | 866 | 0.150 |
Why?
|
| Area Under Curve | 3 | 2021 | 1638 | 0.150 |
Why?
|
| Diet Surveys | 2 | 2021 | 1159 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1731 | 0.150 |
Why?
|
| Granzymes | 1 | 2019 | 278 | 0.150 |
Why?
|
| Aged, 80 and over | 10 | 2022 | 59489 | 0.150 |
Why?
|
| Steroids | 1 | 2023 | 933 | 0.150 |
Why?
|
| Lung Injury | 1 | 2022 | 430 | 0.150 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 12056 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12976 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 518 | 0.140 |
Why?
|
| Occupational Therapy | 1 | 2019 | 140 | 0.140 |
Why?
|
| Respiration, Artificial | 4 | 2022 | 2709 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39193 | 0.140 |
Why?
|
| Mass Media | 1 | 2020 | 301 | 0.140 |
Why?
|
| Obesity, Abdominal | 1 | 2020 | 369 | 0.140 |
Why?
|
| Demography | 1 | 2022 | 1641 | 0.140 |
Why?
|
| Medical History Taking | 1 | 2021 | 777 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2023 | 6309 | 0.140 |
Why?
|
| Genome-Wide Association Study | 4 | 2024 | 12807 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2022 | 597 | 0.130 |
Why?
|
| Sweden | 1 | 2020 | 1381 | 0.130 |
Why?
|
| Interinstitutional Relations | 1 | 2018 | 234 | 0.130 |
Why?
|
| Citrulline | 1 | 2016 | 106 | 0.130 |
Why?
|
| Military Medicine | 1 | 2018 | 185 | 0.130 |
Why?
|
| Metabolome | 2 | 2020 | 1005 | 0.130 |
Why?
|
| Life Change Events | 1 | 2021 | 954 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 594 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2022 | 845 | 0.130 |
Why?
|
| Chemokines | 1 | 2020 | 956 | 0.130 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 786 | 0.130 |
Why?
|
| Epidemiologic Studies | 1 | 2019 | 677 | 0.130 |
Why?
|
| Myocarditis | 1 | 2023 | 802 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2024 | 2446 | 0.120 |
Why?
|
| Rheumatic Fever | 1 | 2015 | 73 | 0.120 |
Why?
|
| Osteonecrosis | 1 | 2017 | 230 | 0.120 |
Why?
|
| Communication | 2 | 2020 | 3916 | 0.120 |
Why?
|
| Needs Assessment | 2 | 2019 | 1138 | 0.120 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 533 | 0.120 |
Why?
|
| Prognosis | 3 | 2021 | 29922 | 0.120 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2018 | 305 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2020 | 1339 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2020 | 553 | 0.120 |
Why?
|
| Publishing | 1 | 2022 | 835 | 0.120 |
Why?
|
| Arginine | 1 | 2018 | 933 | 0.120 |
Why?
|
| Military Personnel | 2 | 2021 | 1252 | 0.120 |
Why?
|
| Complementary Therapies | 1 | 2019 | 487 | 0.120 |
Why?
|
| Electronic Health Records | 2 | 2024 | 4873 | 0.120 |
Why?
|
| HLA-B27 Antigen | 1 | 2014 | 66 | 0.120 |
Why?
|
| Genes, MHC Class II | 1 | 2015 | 433 | 0.120 |
Why?
|
| Fibrinogen | 1 | 2018 | 895 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 452 | 0.120 |
Why?
|
| Algorithms | 3 | 2020 | 14071 | 0.110 |
Why?
|
| Nausea | 1 | 2017 | 680 | 0.110 |
Why?
|
| Gastric Mucosa | 1 | 2017 | 602 | 0.110 |
Why?
|
| Hematinics | 1 | 2017 | 282 | 0.110 |
Why?
|
| Vomiting | 1 | 2017 | 647 | 0.110 |
Why?
|
| Amino Acids | 2 | 2021 | 1709 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2020 | 3458 | 0.110 |
Why?
|
| Carotenoids | 1 | 2017 | 619 | 0.110 |
Why?
|
| Epitopes | 2 | 2017 | 2523 | 0.110 |
Why?
|
| Young Adult | 10 | 2024 | 59889 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 14751 | 0.110 |
Why?
|
| Fibrosis | 1 | 2021 | 2070 | 0.110 |
Why?
|
| Endosonography | 1 | 2017 | 626 | 0.100 |
Why?
|
| Aminolevulinic Acid | 1 | 2014 | 147 | 0.100 |
Why?
|
| Overweight | 2 | 2014 | 2444 | 0.100 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 209 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 753 | 0.100 |
Why?
|
| Research Personnel | 1 | 2018 | 590 | 0.100 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2014 | 157 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 4642 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2233 | 0.100 |
Why?
|
| Antibody Formation | 3 | 2023 | 1391 | 0.100 |
Why?
|
| Physical Examination | 1 | 2019 | 1266 | 0.100 |
Why?
|
| Particulate Matter | 1 | 2024 | 2624 | 0.100 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 241 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20659 | 0.100 |
Why?
|
| Mentors | 1 | 2018 | 671 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2024 | 3081 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2017 | 682 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2021 | 4137 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2020 | 1142 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2017 | 635 | 0.090 |
Why?
|
| Age of Onset | 1 | 2019 | 3344 | 0.090 |
Why?
|
| Weight Gain | 2 | 2022 | 2355 | 0.090 |
Why?
|
| Cytokines | 3 | 2022 | 7421 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2016 | 744 | 0.090 |
Why?
|
| Gastrectomy | 1 | 2015 | 694 | 0.090 |
Why?
|
| Alleles | 4 | 2024 | 6897 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 2247 | 0.090 |
Why?
|
| Cause of Death | 1 | 2021 | 3708 | 0.090 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 26318 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2019 | 1168 | 0.080 |
Why?
|
| Health Communication | 1 | 2013 | 216 | 0.080 |
Why?
|
| China | 3 | 2020 | 2385 | 0.080 |
Why?
|
| Hospitals, Teaching | 1 | 2014 | 1158 | 0.080 |
Why?
|
| Menopause | 1 | 2017 | 1659 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1102 | 0.080 |
Why?
|
| Lower Extremity | 1 | 2017 | 1226 | 0.080 |
Why?
|
| Chloroquine | 2 | 2020 | 276 | 0.080 |
Why?
|
| Kidney | 2 | 2021 | 7066 | 0.080 |
Why?
|
| Azithromycin | 2 | 2020 | 201 | 0.080 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 6544 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2021 | 2897 | 0.080 |
Why?
|
| Clinical Trials as Topic | 2 | 2025 | 8041 | 0.070 |
Why?
|
| Phenotype | 3 | 2017 | 16721 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2017 | 10070 | 0.070 |
Why?
|
| Motivation | 1 | 2018 | 2018 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6499 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 11888 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 3850 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2822 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2019 | 2517 | 0.070 |
Why?
|
| Disease | 1 | 2013 | 676 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2015 | 820 | 0.070 |
Why?
|
| Societies, Medical | 3 | 2024 | 3956 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1884 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 2429 | 0.070 |
Why?
|
| Recurrence | 1 | 2019 | 8501 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 10261 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2018 | 2521 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3615 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2024 | 6610 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2418 | 0.060 |
Why?
|
| Intestines | 1 | 2014 | 1906 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5389 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 18293 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1808 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5719 | 0.060 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2024 | 32 | 0.060 |
Why?
|
| International Classification of Diseases | 2 | 2023 | 935 | 0.060 |
Why?
|
| Adolescent | 7 | 2024 | 88835 | 0.060 |
Why?
|
| Weight Loss | 1 | 2015 | 2710 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2015 | 2039 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 158 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7838 | 0.050 |
Why?
|
| Child | 4 | 2023 | 80564 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7478 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9338 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2018 | 3424 | 0.050 |
Why?
|
| Biopsy | 1 | 2014 | 6763 | 0.050 |
Why?
|
| Endemic Diseases | 1 | 2023 | 189 | 0.050 |
Why?
|
| Sjogren's Syndrome | 1 | 2024 | 239 | 0.050 |
Why?
|
| Ireland | 1 | 2022 | 170 | 0.050 |
Why?
|
| Fast Foods | 1 | 2024 | 220 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3835 | 0.050 |
Why?
|
| Models, Structural | 1 | 2022 | 338 | 0.050 |
Why?
|
| Ritonavir | 1 | 2023 | 330 | 0.050 |
Why?
|
| Prednisolone | 1 | 2022 | 324 | 0.050 |
Why?
|
| B-Cell Activating Factor | 1 | 2021 | 115 | 0.050 |
Why?
|
| Synovial Fluid | 1 | 2023 | 385 | 0.050 |
Why?
|
| Fabaceae | 1 | 2021 | 103 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 4778 | 0.050 |
Why?
|
| Putrescine | 1 | 2020 | 42 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2021 | 71 | 0.040 |
Why?
|
| Butyric Acid | 1 | 2020 | 51 | 0.040 |
Why?
|
| Spermidine | 1 | 2020 | 63 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2021 | 8067 | 0.040 |
Why?
|
| Spondylarthropathies | 1 | 2020 | 13 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 2020 | 128 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 503 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 629 | 0.040 |
Why?
|
| Caprylates | 1 | 2020 | 114 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 4348 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2023 | 536 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36532 | 0.040 |
Why?
|
| Carnitine | 1 | 2020 | 253 | 0.040 |
Why?
|
| Azetidines | 1 | 2020 | 150 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 734 | 0.040 |
Why?
|
| Nuts | 1 | 2021 | 265 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 297 | 0.040 |
Why?
|
| Translations | 1 | 2019 | 84 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 189 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 722 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2022 | 513 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 98 | 0.040 |
Why?
|
| Linear Models | 2 | 2020 | 5876 | 0.040 |
Why?
|
| Tryptophan | 1 | 2020 | 483 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 975 | 0.040 |
Why?
|
| Mass Screening | 2 | 2024 | 5446 | 0.040 |
Why?
|
| Immunotherapy | 2 | 2024 | 4752 | 0.040 |
Why?
|
| Methionine | 1 | 2020 | 569 | 0.040 |
Why?
|
| Diet Records | 1 | 2019 | 425 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20124 | 0.040 |
Why?
|
| Transaminases | 1 | 2018 | 199 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 11499 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2022 | 550 | 0.040 |
Why?
|
| Interleukins | 1 | 2022 | 791 | 0.040 |
Why?
|
| Telomere | 1 | 2024 | 943 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8875 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2023 | 26346 | 0.030 |
Why?
|
| Purines | 1 | 2020 | 615 | 0.030 |
Why?
|
| Self Report | 2 | 2022 | 3770 | 0.030 |
Why?
|
| DNA | 2 | 2021 | 7202 | 0.030 |
Why?
|
| Phosphofructokinase-2 | 1 | 2016 | 33 | 0.030 |
Why?
|
| Beer | 1 | 2017 | 134 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2018 | 318 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2021 | 575 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2020 | 932 | 0.030 |
Why?
|
| Propensity Score | 1 | 2024 | 1968 | 0.030 |
Why?
|
| Wine | 1 | 2017 | 172 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 1801 | 0.030 |
Why?
|
| Kinetics | 1 | 2024 | 6274 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 669 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2021 | 1183 | 0.030 |
Why?
|
| Fatigue | 1 | 2023 | 1549 | 0.030 |
Why?
|
| Piperidines | 1 | 2024 | 1664 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 527 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1831 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2108 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2024 | 2485 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2019 | 634 | 0.030 |
Why?
|
| Pregnancy | 3 | 2023 | 30260 | 0.030 |
Why?
|
| Placebos | 1 | 2020 | 1659 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14652 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4562 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2018 | 514 | 0.030 |
Why?
|
| Menarche | 1 | 2017 | 532 | 0.030 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 746 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 1880 | 0.030 |
Why?
|
| HLA-B Antigens | 1 | 2015 | 329 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2025 | 5501 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3620 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2018 | 2910 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2844 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 1915 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 1028 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2024 | 3047 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 3685 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2019 | 745 | 0.020 |
Why?
|
| Program Development | 1 | 2018 | 1295 | 0.020 |
Why?
|
| Fear | 1 | 2020 | 1499 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3386 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
| Acute Disease | 1 | 2022 | 7232 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 2003 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1811 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2020 | 1984 | 0.020 |
Why?
|
| Genomics | 2 | 2020 | 5929 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2018 | 1051 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 1509 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 2033 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2016 | 786 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2016 | 1896 | 0.020 |
Why?
|
| Anthropometry | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2966 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2022 | 2283 | 0.020 |
Why?
|
| Haplotypes | 1 | 2015 | 2728 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12768 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3222 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9347 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 3139 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2141 | 0.020 |
Why?
|
| Animals | 3 | 2024 | 168764 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2022 | 18973 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 13024 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 3449 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81819 | 0.010 |
Why?
|
| Curriculum | 1 | 2018 | 3782 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14448 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2018 | 8532 | 0.010 |
Why?
|
| Medicare | 1 | 2020 | 6823 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22332 | 0.010 |
Why?
|
| Mutation | 1 | 2024 | 30198 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36386 | 0.010 |
Why?
|
| Stroke | 1 | 2018 | 9747 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 12240 | 0.010 |
Why?
|